Verapamil Induces Upregulation of P-glycoprotein Expression on Human Monocyte Derived Dendritic Cells

REFERENCES

• Abbaszadegan M. R., Cress A. E., Futscher B. W., Bellamy W. T., Dalton W. S. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Cancer Res. 1996a; 56: 5435–5442, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Abbaszadegan M. R., Foley N. E., Gleason-Guzman M. C., Dalton W. S. Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line. Internat. J. Can. 1996b; 66: 506–514, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bosch I., Dunussi-Joannopoulos K., Wu R. L., Furlong S. T., Croop J. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. Biochemistry 1997; 36: 5685–5694, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bucana C. D., Giavazzi R., Nayar R., O'Brian C. A., Seid C., Earnest L. E., Fan D. Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin selected murine fibrosarcoma variants. Exp. Cell Res. 1990; 190: 69–95, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chao D., Bahl P., Houlbrook S., Hoy L., Harris A., Austyn J. M. Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay. Brit. J. Can. 1999; 81: 1280–1284, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cho C. W., Liu Y., Yan X., Henthorn T., Ng K. Y. Carrier-mediated uptake of rhodamine 123: implications on its use for MDR research. Biochem. Biophys. Res. Comm. 2000; 279: 124–130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Drach D., Zhao S., Drach J., Mahadevia R., Gattringer C., Huber H., Andreeff M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 1992; 80: 2729–34, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Higgins C. F. P-glycoprotein and cell volume-activated chloride channels. J. Bioenerg. Biomemb. 1995; 27: 63–70, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Higgins C. F., Linton K. J. Structural biology. The xyz of ABC transporters. Science. 2001; 293: 1782–1784, [CSA]
   Google Scholar
• Ishri R. K., Menzies S., Hersy P., Halliday G. M. Rapid downregulation of antigen processing enzymes in ex vivo generated human monocyte derived dendritic cells occue endogenously in extended cultures. Immunol. Cell Biol. 2004; 82: 239–246, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Janeway C. A. J., Travers P., Walport M., Capra J. D. Immunobiology. Current Biology Publications. 4th. Elsevier Science Ltd/Garland Publishing, London 1999
   Google Scholar
• Kanto T., Kalinski P., Hunter O. C., Lotze M. T., Amoscato A. A. Ceramide mediates tumor-induced dendritic cell apoptosis. J. Immunol. 2001; 167: 3773–3784, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Laupeze B., Amiot L., Bertho N., Grosset J. M., Lehne G., Fauchet R., Fardel O. Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. Human Immunol. 2001; 62: 1073–1080, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lautier D., Canitrot Y., Salmon J. M. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells. Anticancer Res. 1994; 14: 2589–2595, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Lavie Y., Fiucci G., Czarny M., Liscovitch M. Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells. Lipids 1999; 34: S57–63, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Liu Y. Y., Han T. Y., Giuliano A. E., Cabot M. C. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J. Biol. Chem. 1999; 274: 1140–1146, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Liu Y. Y., Han T. Y., Giuliano A. E., Hansen N., Cabot M. C. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J. Biol. Chem. 2000; 275: 7138–7143, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ludescher C., Thaler J., Drach D., Drach J., Spitaler M., Gattringer C., Huber H., Hofmann J. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Brit. J. Haematol. 1992; 82: 161–168, [CSA]
   PubMed Web of Science ®Google Scholar
• Marks D. C., Davey M. W., Davey R. A., Kidman A. D. Differentiation and multidrug resistance in response to drug treatment in the K562 human leukaemia cell line. Brit. J. Haematol. 1993; 84: 83–89, [CSA]
   Google Scholar
• Muller W. A., Randolph G. J. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J. Leuk. Biol. 1999; 66: 698–704, [CSA]
   PubMed Web of Science ®Google Scholar
• Murray R. K., Mayes P. A., Rodwell V. W., Granner D. K. Harper's Biochemistry. 26th. McGraw-Hill Medical Publishing Division, New York 2000
   Google Scholar
• Nelson E. J., Zinkin N. T., Hinkle P. M. Fluorescence methods to assess multidrug resistance in individual cells. Cancer Chemother. Pharmacol. 1998; 42: 292–299, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pinedo H. M., Giaccone G. P-Glycoprotein — a marker of cancer-cell behaviour. [Editorial]. N. Engl. J. Mal. 1995; 333: 1417–1419, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Randolph G. J., Beaulieu S., Lebecque S., Steinman R. M., Muller W. A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. [Report]. Science 1998; 282: 480–483, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Randolph G. J., Beaulieu S., Pope M., Sugawara I., Hoffman L., Steinman R. M., Muller W. A. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. 1998; 95: 6924–6929, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sallusto F., Nicolo C., De Maria R., Corinti S., Testi R. Ceramide inhibits antigen uptake and presentation by dendritic cells. J. Ex. Med. 1996; 184: 2411–2416, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schinkel A. H., Borst P. Multidrug resistance mediated by P-glycoproteins. Semin. Can. Biol. 1991; 2: 213–226, [CSA]
   PubMedGoogle Scholar
• Schroeijers A. B., Reurs A. W., Scheffer G. L., Stam A. G., de Jong M. C., Rustemeyer T., Wiemer E. A., de Gruijl T. D., Scheper R. J. Up-regulation of drug resistance-related vaults during dendritic cell development. J. Immunol. 2002; 168: 1572–1578, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Smital T., Sauerborn R., Pivcevic B., Krca C., Kurelec B. Interspecies differences in P-glycoprotein mediated activity of multixenobiotic resistance mechanism in several marine and freshwater invertebrates. Comp. Biochem. Physio. C: Comp. Pharmacol. Toxicol. 2000; 126: 175–186, [CSA]
   PubMed Web of Science ®Google Scholar
• Su G. M., Davey M. W., Davey R. A., Kidman A. D. Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells. Brit. J. Haematol. 1994; 88: 566–574, [CSA]
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Lida H., Tsukagoshi S., Sakurai Y. Overcoming of vincristine resistance of P388 leukaemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981; 41: 1967–1972, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• van Helvoort A., Giudici M. L., Thielemans M., van Meer G. Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J. Cell Sci. 1997; 110: 75–83, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar